The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
85320053 8532005 3 F 20120408 20160921 20120426 20160929 EXP US-ASTRAZENECA-2012SE25469 ASTRAZENECA 30702.00 DY M Y 99.80000 KG 20160929 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
85320053 8532005 1 PS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 160 MCG, ONE PUFF DAILY 21929
85320053 8532005 2 SS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 160/4.5 MCG, TWO PUFFS A DAY 21929
85320053 8532005 3 SS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 160/4.5 MCG, ONE PUFF A DAY 21929
85320053 8532005 4 C VITAMINS NOS VITAMINS 1 0
85320053 8532005 5 C SIMVASTATIN. SIMVASTATIN 1 0
85320053 8532005 6 C LOSARTAN. LOSARTAN 1 0
85320053 8532005 7 C SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Respiratory (inhalation) 1 PUFF PER DAY 0
85320053 8532005 8 C INJECTION INTO RIGHT EYE 2 0
85320053 8532005 9 C FLUOXETINE FLUOXETINE HYDROCHLORIDE 1 ABOUT 1 WEEK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
85320053 8532005 1 Chronic obstructive pulmonary disease
85320053 8532005 2 Chronic obstructive pulmonary disease
85320053 8532005 3 Chronic obstructive pulmonary disease
85320053 8532005 5 Blood cholesterol abnormal
85320053 8532005 6 Hypertension
85320053 8532005 7 Chronic obstructive pulmonary disease
85320053 8532005 8 Haemorrhage prophylaxis
85320053 8532005 9 Depression

Outcome of event

Event ID CASEID OUTC COD
85320053 8532005 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
85320053 8532005 Blood cholesterol increased
85320053 8532005 Diarrhoea
85320053 8532005 Flatulence
85320053 8532005 Headache
85320053 8532005 Herpes zoster
85320053 8532005 Hypertension
85320053 8532005 Intentional product misuse
85320053 8532005 Nausea
85320053 8532005 Off label use
85320053 8532005 Vision blurred
85320053 8532005 Visual acuity reduced

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
85320053 8532005 1 201202 0
85320053 8532005 2 20160708 0
85320053 8532005 3 20160708 0
85320053 8532005 7 2006 0